Fig. 5

Three-year ROC curves of Gleason score and pathologic T stage (A, C) and five-year ROC curves of Gleason score and pathologic T stage for predicting the biochemical recurrence-free survival of PCa patients. The AUCs of T stage and Gleason score were lower than those of the nomogram model. AUC, area under the curve; ROC, receiver operating characteristic; PCa, prostate cancer